Previous studies from this laboratory have demonstrated that, at least, 2 protein fractions can be prepared from cell and calcium-free human plasma -which have a definite effect of lowering the coagulation time of hemophilic blood (1 to 4). One of these protein fractions requires the presence of both calcium ion and prothrombin in order to exhibit its activity. The other acts as a true thrombin since it can convert fibrinogen to fibrin in the absence of calcium and prothrombin.
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It has been further demonstrated that the former protein preparation, presumably associated with the euglobulin fraction, can by treatment with chloroform be converted into a protein preparation having proteolytic activity (5, 6) . The physiologic role of this enzyme has not been determined. However, it is known that it can convert prothrombin to thrombin and hence in appropriate amounts induce blood coagulation (7) . In larger amounts it can digest fibrinogen before fibrin formation can take place.
Various preparations of globulin fractions from pooled normal human plasma were placed at our disposal for study of their coagulation properties.3 A summary of our results has been presented by other workers (8) .
The present communication concerns the activity of these globulin fractions in vitro. In accompanying paper a brief preliminary note on the in vivo action of one of them is presented.
GENERAL METHODS
All fractions of globulins and parent plasmas were received as dry powder and were put into 4 per cent solution in either isotonic salt solution or in 0.25 per cent sodium citrate in 0.85 per cent sodium chloride solution. The pH of the solutions was adjusted to 7.0 to 7.5 using a glass electrode. The total nitrogen of the final centrifuged solution was determined by a micro Kjeldahl method. The nomenclature used in the description of the fractions was that developed by Cohn and his coworkers (9) . Over 140 globulin fractions have been studied. Most of these studies were made during the period of standardization of methods of preparation and will not be reported because the final fractions were not comparable. The fractions presented in this communication are those obtained after the methods of preparation had been satisfactorily standardized so that duplication of results from fraction to fraction was possible.
The average composition of the various fractions mentioned in this paper are stated in Table I.4 DEFINITIONS AND METHODS Fibrinogen is that fraction of the plasma protein which coagulates on the addition of thrombin alone. It was tested for by the addition of 0.1 ml. of a 12.5 per cent solution of a highly potent thrombin solution 5 to 1 ml. of a 4 per cent solution of the fraction. The time of coagulation, if such occurred, was used as an index of the presence of and a rough quantitative approximation of the amount of fibrinogen.
Prothrombin is the precoursor of thrombin. It rapidly develops thrombic activity on the addition of thromboplastin and calcium ions. A similar conversion can be made by the action of certain 4These are as given by Cohn, Oncley, Strong, Hughes, and Armstrong (9).
6 Lederle "Hemostatic Globulin" (4). proteolytic enzymes with and without calcium ions (10, 7) and under certain circumstances spontaneously (11) . The detection of prothrombin in a fraction of the plasma globulin was made by a modification (12) of Quick's (13) procedure. Instead of the customary 0.1 ml. of plasma, 0.1 ml. of a 4 per cent solution of the fraction was used. When the fraction contained no fibrinogen, this material in the purest form obtainable was added in the reaction vessel before the addition of calcium and thromboplastin. Since all preparations were studied in 4 per cent concentration, the "prothrombin time" was a rough index of the amount present.
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Thrombin is that activity developed in plasma which can convert fibrinogen to fibrin without the intervention of either calcium ion or thromboplastin. The presence of thrombin in a fraction was tested for by the addition of 0.5 ml. of a 4 per cent solution of the fraction to 0.5 ml. of a solution of the purest obtainable fibrinogen. The test was always carried out in the presence of an excess of sodium citrate.
Anti-hemophilic activity [plasma thromboplastin of Howell (14) ] has been shown to be associated with the plasma euglobulins (1, 3) . It is capable in the presence of calcium ions of producing thrombin from prothrombin or alternatively of neutralizing a circulating antithrombin. The antihemophilic activity of a fraction was determined by measuring the effect of 0.1 ml. of a 4 per cent solution of the fraction at 37.5°C. and pH 7 to 7.5 on the coagulation time of 2 ml. of hemophilic blood. Usually 2 dilutions of the 4 per cent solution of the protein fraction with 0.85 per cent saline solution to 1/10 and 1/100 of the former concentration were made. When fractions were extremely active there was marked reduction of the clotting time of the hemophilic blood even at 1/100 dilution. Sometimes activity was found at 1/10 and 1/100 but none when the undiluted material was used. This was presumably due to excessive amounts of citrate ion present in the protein fraction. Proteolytic activity after chloroform. Twentyfive ml. of a 4 per cent solution of the preparation was shaken briefly with 1/10 its volume of chloroform as previously described (7, 5 The results are somewhat obscured due to the presence of traces of preformed thrombin in the fraction. Actually the amount present was so small that over 1 hour was required to obtain a clot with pure fibrinogen solution. It is possible, therefore, that while the small amount of thrombin present, and also the small amount of protease, may have enhanced the antihemophilic activity, they did not account for the marked reduction in the clotting time observed. It is also noteworthy that while Fraction III-2 contains antihemophilic activity, it is devoid of fibrinogen.
Plasma proteolytic enzyme. It will be observed that a proteolytic enzyme after treatment with chloroform can be obtained from the parent plasma and from all of the main fractions studied. The parent plasma contains more of the enzyme than any of the sub-fractions. It is to be noted that the protein content of the plasma is in close proximity to the values obtained for the 4 per cent solutions of the fractions. Of the fractions themselves, the greatest concentration of the enzyme is obtained in Fraction IV which is devoid of fibrinogen and of antihemophilic activity. Hence, it would appear that certain fractions can be a good source for the preparation of the plasma proteolytic enzyme in the absence of antihemophilic activity. The amount of prothrombin present is also usually small in Fraction IV. In Fraction III the fibrinolytic enzyme is largely concentrated in Fraction III-2 which also is capable of lytic action on fibrinogen without the previous preparation with chloroform. Similar lytic action is occasionally found in Fraction I and probably accounts for the instability of solutions of this fraction (16) . Spontaneous clotting and lysis of solutions of Fraction I have been frequently observed as indicated in the table.
Prothrombin and thrombin. The plasma prothrombin was found chiefly in Fraction II + III and occasionally in Fraction IV. Only minute traces remained in the parent plasma. Traces of preformed thrombin are occasionally found, chiefly in Fraction III-2.
Fibrinogen. As would be expected from previous reports (9), fibrinogen was largely found in Fraction I with occasional traces present in Fraction II + III. Fraction IV contained no fibrinogen.
DISCUSSION
Interest centers chiefly around the occurrence and distribution of antihemophilic and proteolytic activity in the various fractions and sub-fractions of the plasma globulins. The separation of a highly potent antihemophilic fraction capable of administration in small amounts to hemophilic patients is desirable. Previous investigations at this laboratory have shown that prothrombin and fibrinogen can be separated from the antihemophilic globulin (2) . This separation in Fraction I has not yet been accomplished. However, Fraction III-2 contains marked antihemophilic activity but no fibrinogen, so that one may hope for a satisfactory separation in the near future.
The finding that proteolytic activity could be obtained by the treatment of Fraction IV by chloroform is of some academic interest. It clearly shows that fractions containing no antihemophilic activity may be a source of proteolytic enzyme. However, it should be borne in mind that the antihemophilic property of plasma is very labile so that in the preparation of Fraction IV it may have been destroyed. Furthermore, it has been shown (1) that there is a great possibility for adsorption of the antihemophilic property on fibrinogen and since this material has been removed before the preparation of Fraction IV, much of the antihemophilic activity might well be removed with it. The high potency of Fraction I which contains 60 to 70 per cent of the fibrinogen would partially confirm this possibility.
Antihemophilic activity quite often is adsorbed (17) . Hence, either in the preparation of Fraction I the plasma contained much more of the antihemophilic material than the specimens examined in the dried state or the concentration of the fibrinogen in this fraction served also to concentrate the minimal amounts of the antihemophilic activity remaining in the parent plasma.
The presence of a protease in Fraction I confirms to a large degree our opinion regarding the cause of the instability of fibrinogen solutions. It has been noted in this laboratory that in the presence of plasma protease fibrinogen solutions clot and the clot lyses within a short time (17) .
The foregoing in vitro observations suggest that by further subfractionation a highly potent injectable material may be found which may have some value in the treatment of hemophilic patients. Preliminary observations of the effect of injection in hemophilia of a suitable fraction for the commencement of such chemical fractionation are given in the accompanying paper. Furthermore, the data suggest that from Fraction III-2 or Fraction IV a sub-fraction may be obtained which will be a highly potent source of the proteolytic enzyme (7, 5 2. The plasma proteolytic enzyme (7, 5 ) may be prepared from Fractions I, II + III, and IV. In Fractions I and III-2 a proteolytic activity without treatment with chloroform can occasionally be demonstrated.
3. The proteolytic activity after treatment with chloroform can be obtained from Fraction IV which is devoid of antihemophilic activity, fibrinogen and prothrombin.
